γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer.

[1]  M. Manns,et al.  Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. , 2013, Journal of hepatology.

[2]  Zhaoshi Jiang,et al.  An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy , 2013, Nature Medicine.

[3]  M. Sade-Feldman,et al.  Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. , 2013, Immunity.

[4]  Elizabeth E Gray,et al.  IL-17-committed Vγ4+ γδ T cell deficiency in a spontaneous Sox13 mutant CD45.1 congenic mouse substrain protects from dermatitis , 2013, Nature Immunology.

[5]  V. Soumelis,et al.  Human inflammatory dendritic cells induce Th17 cell differentiation. , 2013, Immunity.

[6]  P. Vantourout,et al.  Six-of-the-best: unique contributions of γδ T cells to immunology , 2013, Nature Reviews Immunology.

[7]  R. Sun,et al.  High‐mobility group box 1 (HMGB1)‐toll‐like receptor (TLR)4‐interleukin (IL)‐23‐IL‐17A axis in drug‐induced damage‐associated lethal hepatitis: Interaction of γδ T cells with macrophages , 2013, Hepatology.

[8]  C. Datz,et al.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth , 2012, Nature.

[9]  U. Syrbe,et al.  TNF signaling drives myeloid-derived suppressor cell accumulation. , 2012, The Journal of clinical investigation.

[10]  A. Macpherson,et al.  Interactions Between the Microbiota and the Immune System , 2012, Science.

[11]  B. Becher,et al.  Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. , 2012, The Journal of clinical investigation.

[12]  L. Bradbury,et al.  Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. , 2012, Arthritis and rheumatism.

[13]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[14]  V. Jala,et al.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.

[15]  M. Todaro,et al.  Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells. , 2011, Blood.

[16]  J. M. Mullin,et al.  Epithelial Tight Junctional Changes in Colorectal Cancer Tissues , 2011, TheScientificWorldJournal.

[17]  J. Galon,et al.  Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. , 2011, Cancer research.

[18]  S. Ghosh,et al.  T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells. , 2010, Immunity.

[19]  A. Algra,et al.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.

[20]  V. Kuchroo,et al.  γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. , 2010, Immunity.

[21]  B. Silva-Santos.  Promoting angiogenesis within the tumor microenvironment: The secret life of murine lymphoid IL‐17‐producing γδ T cells , 2010, European journal of immunology.

[22]  Y. Iwakura,et al.  Tumor‐infiltrating IL‐17‐producing γδ T cells support the progression of tumor by promoting angiogenesis , 2010, European journal of immunology.

[23]  W. Zou,et al.  TH17 cells in tumour immunity and immunotherapy , 2010, Nature Reviews Immunology.

[24]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[25]  C. Elmets,et al.  IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells , 2010, The Journal of Immunology.

[26]  Cynthia L Sears,et al.  A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.

[27]  K. Mills,et al.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. , 2009, Immunity.

[28]  J. Farber,et al.  CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. , 2009, The Journal of clinical investigation.

[29]  T. Iwaki,et al.  Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury , 2009, Nature Medicine.

[30]  A. Poggi,et al.  Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. , 2009, Blood.

[31]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[32]  T. Mcclanahan,et al.  IL-23 promotes tumour incidence and growth , 2006, Nature.

[33]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[34]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[35]  B. Aronow,et al.  Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. , 2005, Cancer research.

[36]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[37]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.